.
AMBUJACEM financial statements
* Numbers in millions
| Capitalization * | 582 688 |
|---|---|
| EV * | 402 197 |
| Number of shares * | 1 986 |
| EPS | 11,91 |
| Revenue * | 240 939 |
| Net income * | 23 654 |
| Operating profit * | 38 707 |
| Total liabilities * | 106 222 |
| Net debt * | -81 010 |
| Total assets * | 397 206 |
| Equity * | 227 576 |
| Cash and investments * | 86 189 |
.
AMBUJACEM valuation
| P/E | 24,63 |
|---|---|
| P/B | 2,56 |
| P/S | 2,42 |
| E/P | 4 |
| P/FCF | 18,80 |
.
AMBUJACEM profitability
| ROE | 10% |
|---|---|
| ROA% | 7% |
| ROIC% | 13% |